Insufficient scRNA-seq data for expression of CACNA1S at single-cell level.
Insufficient scRNA-seq data for expression of CACNA1S at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
muscle | 100% | 24987.26 | 803 / 803 | 0% | 0 | 0 / 0 |
brain | 74% | 53.46 | 1953 / 2642 | 5% | 0.15 | 34 / 705 |
kidney | 76% | 41.69 | 68 / 89 | 1% | 0.03 | 7 / 901 |
lung | 74% | 32.03 | 428 / 578 | 1% | 0.05 | 16 / 1155 |
blood vessel | 62% | 63.53 | 822 / 1335 | 0% | 0 | 0 / 0 |
intestine | 38% | 10.15 | 364 / 966 | 1% | 0.05 | 5 / 527 |
heart | 38% | 9.07 | 327 / 861 | 0% | 0 | 0 / 0 |
adipose | 37% | 14.04 | 451 / 1204 | 0% | 0 | 0 / 0 |
spleen | 31% | 7.68 | 74 / 241 | 0% | 0 | 0 / 0 |
bladder | 29% | 5.95 | 6 / 21 | 1% | 0.05 | 4 / 504 |
skin | 26% | 14.11 | 474 / 1809 | 1% | 0.01 | 3 / 472 |
prostate | 20% | 73.02 | 48 / 245 | 7% | 0.74 | 33 / 502 |
stomach | 24% | 5.19 | 87 / 359 | 1% | 0.01 | 2 / 286 |
esophagus | 24% | 10.98 | 344 / 1445 | 1% | 0.01 | 2 / 183 |
thymus | 21% | 12.14 | 139 / 653 | 1% | 0.05 | 5 / 605 |
uterus | 16% | 3.28 | 27 / 170 | 5% | 1.47 | 22 / 459 |
breast | 19% | 14.26 | 86 / 459 | 0% | 0.08 | 5 / 1118 |
ovary | 18% | 4.22 | 33 / 180 | 0% | 0.00 | 1 / 430 |
peripheral blood | 16% | 24.58 | 147 / 929 | 0% | 0 | 0 / 0 |
pancreas | 10% | 1.88 | 32 / 328 | 0% | 0 | 0 / 178 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.80 | 4 / 45 |
liver | 6% | 1.58 | 14 / 226 | 1% | 0.03 | 5 / 406 |
adrenal gland | 5% | 0.84 | 12 / 258 | 0% | 0.01 | 1 / 230 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006941 | Biological process | striated muscle contraction |
GO_0045933 | Biological process | positive regulation of muscle contraction |
GO_0043501 | Biological process | skeletal muscle adaptation |
GO_0048741 | Biological process | skeletal muscle fiber development |
GO_0007029 | Biological process | endoplasmic reticulum organization |
GO_0098703 | Biological process | calcium ion import across plasma membrane |
GO_0002074 | Biological process | extraocular skeletal muscle development |
GO_0006936 | Biological process | muscle contraction |
GO_0051209 | Biological process | release of sequestered calcium ion into cytosol |
GO_0007528 | Biological process | neuromuscular junction development |
GO_0001501 | Biological process | skeletal system development |
GO_0007520 | Biological process | myoblast fusion |
GO_0006816 | Biological process | calcium ion transport |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0071313 | Biological process | cellular response to caffeine |
GO_0005886 | Cellular component | plasma membrane |
GO_1990454 | Cellular component | L-type voltage-gated calcium channel complex |
GO_0005891 | Cellular component | voltage-gated calcium channel complex |
GO_0030315 | Cellular component | T-tubule |
GO_0031674 | Cellular component | I band |
GO_0016529 | Cellular component | sarcoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_0140677 | Molecular function | molecular function activator activity |
GO_0036094 | Molecular function | small molecule binding |
GO_0005245 | Molecular function | voltage-gated calcium channel activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0008331 | Molecular function | high voltage-gated calcium channel activity |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CACNA1S |
Protein name | Calcium voltage-gated channel subunit alpha1 S Voltage-dependent L-type calcium channel subunit alpha Voltage-dependent L-type calcium channel subunit alpha-1S (Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle) (Voltage-gated calcium channel subunit alpha Cav1.1) |
Synonyms | CACH1 CACN1 CACNL1A3 |
Description | FUNCTION: Pore-forming, alpha-1S subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents in skeletal muscle. Calcium channels containing the alpha-1S subunit play an important role in excitation-contraction coupling in skeletal muscle via their interaction with RYR1, which triggers Ca(2+) release from the sarcoplasmic reticulum and ultimately results in muscle contraction. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. . FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. . |
Accessions | ENST00000681190.1 ENST00000680059.1 A0A7P0T8M7 ENST00000681078.1 ENST00000681874.1 A0A7P0TB53 ENST00000679417.1 B1ALM3 ENST00000367338.7 A0A7P0Z433 ENST00000362061.4 A0A7P0TBR2 A0A7P0TBJ5 Q13698 |